AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pluri Inc. Proxy Solicitation & Information Statement 2020

May 1, 2020

6990_rns_2020-04-30_d2339acf-0888-4263-8e8c-9a3d1a1d0506.htm

Proxy Solicitation & Information Statement

Opens in your device viewer

_________ false


��	2 381
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001	8543
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	30/04/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-043131	Time of broadcast: 23:07 23:06:39

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	PSTI Preliminary Proxy 2020 Annual General Meeting

PSTI_Preliminary_Proxy_2020_Annual_General_Meeting_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 22/04/2020
Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected] Company site: www.pluristem.com

Previous names of reporting entity:

Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1